abstract |
The pharmaceutical composition comprises a water-insoluble solid complex, the formation of which is mediated at least in part by the ionic interactions of the LHRH analogue and the macromolecular carrier, wherein the carrier molecule is water soluble prior to complexing with the LHRH analogue and the LHRH analogue content of said complex is at least 57% by weight. |